Dosing may also take place periodically over a period of time, and the dosage may change (increase or decrease) with time
Machine learning and artificial intelligence techniques may improve MRI interpretation, disease prediction, and treatment response monitoring
Real-world evidence studies, now encompassing hundreds of thousands of patients, generally confirm the clinical trial safety profile while providing insights into effectiveness in more diverse populations and clinical settings
In the well-known randomized controlled VITamin D and OmegA-3 (VITAL) trial, a total of 25,835 people supplemented with either one gram of omega-3s (containing 460 mg eicosapentaenoic acid [EPA] and 380 mg docosahexaenoic acid [DHA]), 50 mcg (2,000 IU) vitamin D, both, or a placebo daily for six years
Cardiovascular events and mortality in people with type 2 diabetes and multimorbidity: a real-world study of patients followed for up to 19 years